Seroconversion after influenza vaccination in patients with lung cancer
1999
Influenza Vaccination Response in Lung Cancer Patients
Sample size: 59
publication
Evidence: moderate
Author Information
Author(s): Anderson H, Petrie K, Berrisford C, Charlett A, Thatcher N, Zambon M
Primary Institution: Wythenshawe Hospital, Manchester, UK
Hypothesis
There is a lack of data on the efficacy of influenza vaccination in lung cancer patients.
Conclusion
The study found that 78% of lung cancer patients responded fully to the influenza vaccine, which is similar to the response rate in healthy volunteers.
Supporting Evidence
- Paired sera were available from 59 patients who received Fluvirin.
- Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination.
- This response rate is comparable to that obtained from healthy volunteers.
Takeaway
Most lung cancer patients can get a good response from the flu shot, just like healthy people do.
Methodology
Paired sera were collected from patients who received the Fluvirin vaccine.
Participant Demographics
Patients with lung cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website